Cargando…
Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia
BACKGROUND: The purpose of this study was to compare plasma soluble endoglin (sEng) levels with standard clinical evaluation or plasma levels of other angiogenic proteins [soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF)] in predicting short-term adverse maternal and per...
Autores principales: | Rana, Sarosh, Cerdeira, Ana Sofia, Wenger, Julia, Salahuddin, Saira, Lim, Kee-Hak, Ralston, Steven J., Thadhani, Ravi I., Karumanchi, S. Ananth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482204/ https://www.ncbi.nlm.nih.gov/pubmed/23110221 http://dx.doi.org/10.1371/journal.pone.0048259 |
Ejemplares similares
-
Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia
por: Palomaki, Glenn E, et al.
Publicado: (2015) -
Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
por: Rana, Sarosh, et al.
Publicado: (2022) -
Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia
por: March, Melissa I., et al.
Publicado: (2015) -
MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2012) -
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
por: Cohen, Allison L., et al.
Publicado: (2014)